NervGen Pharma

NGEN

1.6000.63% ( +0.010 )

Closed: Jul 30, 16:00:00 (EDT)

Financial report interval: 2025.12.31 - 2026.03.31

Preview: NervGen Pharma(NGEN) predict that the EBIT is -7.532 M (--%), Beat estimate;the EPS is -0.0654 (-118.5%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

Revenue

TBA--

0.00B--

----

EBITExceed expectations

-0.01B--

+0.00B--%

EPSExceed expectations

-0.0654118.46%

-0.0675125.47%

+0.00217.01%

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD

ActualEstimateUnit: USD